Skip to main content

Table 1 Clinical characteristics of patients

From: Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma

Patients with pleural effusion

Pulmonary carcinoma (n = 110)

Pneumonia (n = 13)

Tuberculosis (n = 42)

Heart failure/hypoproteinemia(n = 38)

Extrapulmonary carcinoma (n = 6)

Malignant (n = 106)

Nonmalignant (n = 4)

Age ( x ¯ ± S)

63.35 ± 9.35

61.25 ± 6.29

46.23 ± 11.56

43.38 ± 13.88

64.78 ± 8.53

51.17 ± 9.13

Sex (M/F)

55/51

2/2

7/6

20/22

20/18

2/4

Cast-off (N/P)

38/68

4/0

13/0

42/0

38/0

3/3

Pleural biopsy (n)

49

4

—

8

—

3

TNM stage

      

I

—

3

—

—

—

1

II

—

1

—

—

—

1

III

—

—

—

—

—

—

IV

106

—

—

 

—

4

Pathological type

      
 

SCC 26

—

—

—

—

Hepatoma 2

 

Ade 71

—

—

—

—

ovarian cancer 1

 

SCLC 9

—

—

—

—

pleural endotheliomas 1

   

—

—

—

breast cancer 2

Pleural effusion ( x ¯ ± S)

      

PH

7.42 ± 0.05

7.45 ± 0.02

7.18 ± 0.04

7.36 ± 0.04

7.45 ± 0.05

7.48 ± 0.03

LDH

665.48 ± 226.18

203.25 ± 57.64

363.46 ± 64.7

384.93 ± 93.44

135.79 ± 32.38

575.5 ± 152.28

Glu

4.52 ± 0.81

4.87 ± 0.3

4.78 ± 0.53

4.7 ± 0.58

4.74 ± 0.36

4.46 ± 0.77

Alb

46.59 ± 4.84

24.11 ± 1.57

42.47 ± 5.05

47.57 ± 4.59

22.15 ± 2.28

47.93 ± 4.63

  1. Extrapulmonary carcinoma: including breast cancer, pleural endotheliomas, and lymphadenoma; N/P negative/positive, SCC squamous cell carcinoma, Ade adenocarcinoma, SCLC small cell lung cancer, PH power of hydrogen, LDH lactate dehydrogenase, Glu glucose, Alb albumin —: no data.